Bloomberg |
Actelion boosted by critical drug trials
Financial Times By Haig Simonian in Zurich Investors in Actelion breathed a collective sigh of relief on Monday as Europe's biggest biotech group by sales revealed positive test findings for a critical new drug. Basel-based Actelion said a late stage clinical trial … Actelion Says Hypertension Drug Macitentan Met Primary Goals In Pivotal Study Actelion to host Conference Call / Audiocast on SERAPHIN Study Results Actelion Lung Drug Meets Main Goal in Pivotal Patient Study |
Join the conversation and have a little fun at Capitalstool.com. If you are a new visitor to the Stool, please register and join in! To post your observations and charts, and snide, but good-natured, comments, click here to register. Be sure to respond to the confirmation email which is sent instantly. If not in your inbox, check your spam filter.